SCHEMBL12524580

SCHEMBL12524580

CC1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)Cn2cccc2C(N)=N1

nearest known ligand 0.80

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 17/20 0.80
BACE2 Q9Y5Z0 7/20 0.80
KCNH1 O95259 2/20 0.80
APP P05067 1/20 0.64
CYP3A4 P08684 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16312251 1.00 BACE1 (0.80) BACE1BACE2KCNH1APPCYP3A4
SCHEMBL17704793 0.89 BACE1 (1.00) BACE1BACE2KCNH1APPCYP3A4
SCHEMBL12525223 0.89 BACE1 (1.00) BACE1BACE2KCNH1APPCYP3A4
SCHEMBL17699486 0.88 BACE1 (0.81) BACE1BACE2KCNH1APPCYP3A4
SCHEMBL16312280 0.86 BACE1 (1.00) BACE1BACE2KCNH1APPCYP3A4
SCHEMBL10175536 0.86 BACE1 (1.00) BACE1BACE2KCNH1APPCYP3A4
SCHEMBL12494695 0.86 BACE1 (0.71) BACE1BACE2KCNH1
SCHEMBL20677607 0.84 BACE1 (1.00) BACE1BACE2KCNH1APPCYP3A4
SCHEMBL14876661 0.83 BACE1 (1.00) BACE1BACE2APPCYP3A4
SCHEMBL14876637 0.83 BACE1 (1.00) BACE1BACE2APPCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9845326-B2 Substituted 3,4-dihydropyrrolo[1,2-A]pyrazines as beta-secretase (BACE) inhibitors JANSSEN PHARMACEUTICA NV (BE) 2017-12-19 US disclosed
EP-2683721-B1 3,4-DIHYDRO-PYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) JANSSEN PHARMACEUTICA NV (BE) 2015-01-28 EP disclosed
WO-2012120023-A1 3,4-DIHYDRO-PYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) JANSSEN PHARMACEUTICA NV (BE) 2012-09-13 WO disclosed